- Home
- GHRS vs EZPW Comparison
GHRS vs EZPW Comparison
Compare GHRS & EZPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- EZPW
- Stock Information
- Founded
- GHRS 2018
- EZPW 1989
- Country
- GHRS Ireland
- EZPW United States
- Employees
- GHRS N/A
- EZPW N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- EZPW Other Specialty Stores
- Sector
- GHRS Health Care
- EZPW Consumer Discretionary
- Exchange
- GHRS Nasdaq
- EZPW Nasdaq
- Market Cap
- GHRS 753.0M
- EZPW 814.0M
- IPO Year
- GHRS 2021
- EZPW 1991
- Fundamental
- Price
- GHRS $13.08
- EZPW $16.00
- Analyst Decision
- GHRS Strong Buy
- EZPW Strong Buy
- Analyst Count
- GHRS 8
- EZPW 3
- Target Price
- GHRS $30.63
- EZPW $19.33
- AVG Volume (30 Days)
- GHRS 254.5K
- EZPW 801.7K
- Earning Date
- GHRS 08-07-2025
- EZPW 07-30-2025
- Dividend Yield
- GHRS N/A
- EZPW N/A
- EPS Growth
- GHRS N/A
- EZPW 23.23
- EPS
- GHRS N/A
- EZPW 1.29
- Revenue
- GHRS N/A
- EZPW $1,232,018,000.00
- Revenue This Year
- GHRS N/A
- EZPW $9.93
- Revenue Next Year
- GHRS N/A
- EZPW $6.42
- P/E Ratio
- GHRS N/A
- EZPW $12.44
- Revenue Growth
- GHRS N/A
- EZPW 8.31
- 52 Week Low
- GHRS $6.00
- EZPW $10.56
- 52 Week High
- GHRS $20.50
- EZPW $16.60
- Technical
- Relative Strength Index (RSI)
- GHRS 47.54
- EZPW 66.36
- Support Level
- GHRS $11.32
- EZPW $15.42
- Resistance Level
- GHRS $13.15
- EZPW $16.34
- Average True Range (ATR)
- GHRS 0.73
- EZPW 0.35
- MACD
- GHRS 0.05
- EZPW 0.03
- Stochastic Oscillator
- GHRS 77.19
- EZPW 81.01
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About EZPW EZCORP Inc. Non Voting
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.